Trafermin
(Redirected from Fiblast Spray)
Thrombopoiesis is the process by which the body produces platelets, a type of blood cell that is essential for blood clotting. This process is regulated by a hormone called thrombopoietin (TPO), which is primarily produced in the liver and kidney.
Overview[edit | edit source]
Thrombopoiesis begins in the bone marrow, where hematopoietic stem cells (HSCs) differentiate into megakaryocytes, the cells that eventually become platelets. This process is influenced by several factors, including the levels of TPO in the body.
TPO binds to receptors on the surface of HSCs, stimulating them to differentiate into megakaryocytes. These megakaryocytes then undergo a process called endomitosis, in which they replicate their DNA without undergoing cell division. This results in large, multinucleated cells that are capable of producing thousands of platelets each.
Once the megakaryocytes have matured, they extend protrusions called proplatelets into the blood vessels in the bone marrow. These proplatelets are then sheared off by the force of the blood flow, forming individual platelets.
Regulation[edit | edit source]
The regulation of thrombopoiesis is complex and involves several different factors. The primary regulator is TPO, but other factors such as interleukin-6 (IL-6), interleukin-11 (IL-11), and stem cell factor (SCF) also play a role.
TPO levels in the body are regulated by the number of platelets in circulation. When platelet levels are low, TPO production is increased to stimulate the production of more platelets. Conversely, when platelet levels are high, TPO production is decreased to prevent an overproduction of platelets.
Clinical significance[edit | edit source]
Abnormalities in thrombopoiesis can lead to a variety of medical conditions. For example, a decrease in platelet production can lead to thrombocytopenia, a condition characterized by low platelet levels. This can result in excessive bleeding and bruising.
Conversely, an overproduction of platelets can lead to thrombocytosis, which can increase the risk of blood clots and strokes. Understanding the process of thrombopoiesis and its regulation can therefore be important in the diagnosis and treatment of these conditions.
| Trafermin Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
